<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03142477</url>
  </required_header>
  <id_info>
    <org_study_id>52649715.9.0000.5149</org_study_id>
    <nct_id>NCT03142477</nct_id>
  </id_info>
  <brief_title>Effects of Therapeutic Touch in Patients With Female Genital Neoplasia: a Randomized Controlled Clinical Trial</brief_title>
  <official_title>Effects of Therapeutic Touch in Patients With Female Genital Neoplasia: a Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled prospective study on the use of therapeutic touch in patients
      diagnosed with gynecological cancer. The patients will be randomized into three groups:
      control group (will not receive any interventions with therapeutic touch), placebo group
      (will receive simulated therapeutic touch intervention by individual not knowing this
      technique) and treatment group(will receive therapeutic touch intervention by a trained
      therapeutic touch therapist). Two different quality of life questionnaires will be applied
      (before and after treatment). Levels of cortisol, salivary IgA, hematological indices and
      telomerase activity before and after the use of therapeutic touch will be compared between
      groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project is a randomized controlled prospective study on the use of therapeutic touch in
      patients diagnosed with gynecological cancer. The patients will be randomized into three
      groups: control group (will not receive any interventions with therapeutic touch), placebo
      group (will receive simulated therapeutic touch intervention by individual not knowing the
      practice) and treatment group (will receive therapeutic touch intervention by a trained
      therapeutic touch therapist). Two different quality of life questionnaires (World Health
      Organization quality of life questionnaire - WHOQOL-Bref and the quality of life Core-30
      questionnaire - EORTC QLQ-C30) from the European Organization for Research and Treatment of
      Cancer will be applied before and after treatment. Levels of cortisol, salivary IgA,
      hematological indices and telomerase activity before and after the use of therapeutic touch
      will be compared between groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized into tree different groups: control, placebo, treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>up to 16 weeks of follow-up</time_frame>
    <description>Quality of life questionnaire WHOQOL-Bref</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Salivary cortisol</measure>
    <time_frame>Between 10 to 16 weeks</time_frame>
    <description>Salivary cortisol will be measured after the use of therapeutic touch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life 2</measure>
    <time_frame>up to 16 weeks of follow-up</time_frame>
    <description>Quality of life questionnaire EORTC QLQ-C30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Telomerase activity</measure>
    <time_frame>up to 16 weeks of follow-up</time_frame>
    <description>Telomerase activity will be measured after the use of therapeutic touch</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Quality of Life</condition>
  <condition>Gynecologic Neoplasm</condition>
  <condition>Gynecologic Cancer</condition>
  <condition>Palliative Care</condition>
  <condition>Therapeutic Touch</condition>
  <condition>Reiki</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control group patients will not receive any interventions with therapeutic touch. Two different quality of life questionnaires (WHOQOL-Bref and EORTC QLQ-C30) will be applied before and after treatment. Levels of cortisol, salivary IgA, hematological index results and telomerase activity before and after the use of therapeutic touch will be measured.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo patients group patients will receive the therapeutic touch intervention by a graduate student without any therapeutic touch training. Two different quality of life questionnaires (WHOQOL-Bref and EORTC QLQ-C30) will be applied before and after treatment. Levels of cortisol, salivary IgA, hematological index results and telomerase activity before and after the use of therapeutic touch will be measured.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment patients group patients will receive the therapeutic touch interventions with a trained therapeutic touch professional. Two different quality of life questionnaires (WHOQOL-Bref and EORTC QLQ-C30) will be applied before and after treatment. Levels of cortisol, salivary IgA, hematological index results and telomerase activity before and after the use of therapeutic touch will be measured.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Two different quality of life questionnaires (WHOQOL-Bref and EORTC QLQ-C30) will be applied before and after treatment. No true or placebo therapeutic touch intervention will be performed.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo therapeutic touch</intervention_name>
    <description>Placebo therapeutic touch will be done by graduate students without any specific training. The students are instructed to perform the placebo therapeutic touch with no objective intention of improving the patient's health.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Therapeutic touch</intervention_name>
    <description>Therapeutic touch will be done by therapeutic touch trained professionals graduate students without any specific training with the intention of improving the patient's health.</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female patients

          -  age over 18 years

          -  diagnosis of neoplasms of the female genitalia

          -  Signature of the consent form

        Exclusion Criteria:

          -  history of previous contact with the therapeutic touch technique

          -  use of psychotropic drugs, severe neurological or psychiatric disorders that make it
             impossible to participate in the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>eligibility is based on self-representation</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rubens Tavares, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rubens Tavares, MD, PhD</last_name>
    <phone>5531 3409 9485</phone>
    <email>rubens.ufmg@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gelza Nunes, MSc</last_name>
    <phone>5531 3409 9485</phone>
    <email>nunesgelza@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Federal University of Minas Gerais</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30130-100</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rubens Tavares, MD,PhD</last_name>
      <phone>+5531 3409 9485</phone>
      <email>rubens.ufmg@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Gelza Nunes, MSc</last_name>
      <phone>+5531 3409 9485</phone>
      <email>nunesgelza@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2017</study_first_submitted>
  <study_first_submitted_qc>May 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2017</study_first_posted>
  <last_update_submitted>May 4, 2017</last_update_submitted>
  <last_update_submitted_qc>May 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Minas Gerais</investigator_affiliation>
    <investigator_full_name>Rubens Lene Carvalho Tavares</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Therapeutic touch</keyword>
  <keyword>Reiki</keyword>
  <keyword>Laying-on-of-Hands</keyword>
  <keyword>Spiritual Therapies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Genital Neoplasms, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

